Gary Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 22 Year, 4 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.75 Cr
- Satisfied Charges ₹ 5.50 M
- Revenue Growth 20.24%
- Profit Growth 4616.47%
- Ebitda 64.38%
- Net Worth 21.31%
- Total Assets 10.14%
About Gary Pharmaceuticals
Gary Pharmaceuticals Private Limited (GPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 February 2003 and has a history of 22 years. Its registered office is in Ludhiana, Punjab, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.75 Cr. The company has closed loans amounting to ₹5.50 M, as per Ministry of Corporate Affairs (MCA) records.
Ravibir Garewal and Sandip Garewal serve as directors at the Company.
Company Details
-
Location
Ludhiana, Punjab, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24232PB2003PTC025769
-
Company No.
025769
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Feb 2003
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Gary Pharmaceuticals Private Limited offer?
Gary Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Tablets, Pharmaceutical Medicine, Hand Sanitizers & Personal Hygiene, Bath Soaps, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Psoriasis Ointment, Beauty Soap, Cosmetics, Hair & Beauty Products.
Who are the key members and board of directors at Gary Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravibir Garewal
|
Whole-Time Director | 04-Feb-2003 | Current |
|
Sandip Garewal
|
Director | 04-Feb-2003 | Current |
Financial Performance of Gary Pharmaceuticals.
Gary Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.24% increase. The company also saw a substantial improvement in profitability, with a 4616.47% increase in profit. The company's net worth Soared by an impressive increase of 21.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gary Pharmaceuticals?
Unlock access to Gary Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹17.50 M
₹5.50 M
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 1.75 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2018 | Hdfc Bank Limited | ₹1.75 Cr | Open |
| 06 Apr 2004 | Bank Of Baroda | ₹5.50 M | Satisfied |
How Many Employees Work at Gary Pharmaceuticals?
Gary Pharmaceuticals has a workforce of 26 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gary Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gary Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.